Buzatu I, Tataranu L, Duta C, Stoian I, Alexandru O, Dricu A
Int J Mol Sci. 2025; 26(5).
PMID: 40076810
PMC: 11899917.
DOI: 10.3390/ijms26052192.
Mohamed Sajer R, Pendem S, Kadavigere R, - P, Nayak S S, Nayak K
F1000Res. 2025; 14():54.
PMID: 39839989
PMC: 11747303.
DOI: 10.12688/f1000research.160088.1.
Atoki A, Aja P, Shinkafi T, Ondari E, Adeniyi A, Fasogbon I
Fly (Austin). 2024; 19(1):2420453.
PMID: 39722550
PMC: 11702942.
DOI: 10.1080/19336934.2024.2420453.
Shan W, Zuo K, Zuo Z
J Cell Mol Med. 2024; 28(23):e70260.
PMID: 39636301
PMC: 11619449.
DOI: 10.1111/jcmm.70260.
Xia Z, Jin Q, Long Z, He Y, Liu F, Sun C
Nat Biomed Eng. 2024; 8(12):1634-1650.
PMID: 39420062
DOI: 10.1038/s41551-024-01258-8.
Integrating HRMAS-NMR Data and Machine Learning-Assisted Profiling of Metabolite Fluxes to Classify Low- and High-Grade Gliomas.
Firdous S, Nawaz Z, Abid R, Cheng L, Musharraf S, Sadaf S
Interdiscip Sci. 2024; 16(4):854-871.
PMID: 39331335
DOI: 10.1007/s12539-024-00642-x.
Human glioblastoma-derived cell membrane nanovesicles: a novel, cell-specific strategy for boron neutron capture therapy of brain tumors.
Balboni A, Ailuno G, Baldassari S, Drava G, Petretto A, Grinovero N
Sci Rep. 2024; 14(1):19225.
PMID: 39160236
PMC: 11333626.
DOI: 10.1038/s41598-024-69696-7.
A Novel Strategy for Glioblastoma Treatment by Natural Bioactive Molecules Showed a Highly Effective Anti-Cancer Potential.
Giammona A, Commisso M, Bonanomi M, Remedia S, Avesani L, Porro D
Nutrients. 2024; 16(15).
PMID: 39125270
PMC: 11314145.
DOI: 10.3390/nu16152389.
Interaction of NF-κB and FOSL1 drives glioma stemness.
Ramar V, Guo S, Hudson B, Khedri A, Guo A, Li J
Cell Mol Life Sci. 2024; 81(1):255.
PMID: 38856747
PMC: 11335291.
DOI: 10.1007/s00018-024-05293-1.
A Wearable Fluorescence Imaging Device for Intraoperative Identification of Human Brain Tumors.
Mohtasebi M, Huang C, Zhao M, Mazdeyasna S, Liu X, Haratbar S
IEEE J Transl Eng Health Med. 2024; 12:225-232.
PMID: 38196823
PMC: 10776094.
DOI: 10.1109/JTEHM.2023.3338564.
Bivalent activity of super-enhancer RNA LINC02454 controls 3D chromatin structure and regulates glioma sensitivity to temozolomide.
Shi T, Guo D, Zheng Y, Wang W, Bi J, He A
Cell Death Dis. 2024; 15(1):6.
PMID: 38177123
PMC: 10766990.
DOI: 10.1038/s41419-023-06392-w.
The Interaction between Collagen 1 and High Mannose Type CD133 Up-Regulates Glutamine Transporter SLC1A5 to Promote the Tumorigenesis of Glioblastoma Stem Cells.
Wei Y, Geng S, Si Y, Yang Y, Chen Q, Huang S
Adv Sci (Weinh). 2023; 11(3):e2306715.
PMID: 37997289
PMC: 10797482.
DOI: 10.1002/advs.202306715.
Exosomes Interactions with the Blood-Brain Barrier: Implications for Cerebral Disorders and Therapeutics.
Osaid Z, Haider M, Hamoudi R, Harati R
Int J Mol Sci. 2023; 24(21).
PMID: 37958619
PMC: 10648512.
DOI: 10.3390/ijms242115635.
The Anti-hypoxia Potentials of Trans-sodium Crocetinate in Hypoxiarelated Diseases: A Review.
Klunko N, Achmad H, Abdullah T, Mohammed S, Saha I, Salim K
Curr Radiopharm. 2023; 17(1):30-37.
PMID: 37877507
DOI: 10.2174/0118744710268127231020083505.
Carbon Ions for Hypoxic Tumors: Are We Making the Most of Them?.
Sokol O, Durante M
Cancers (Basel). 2023; 15(18).
PMID: 37760464
PMC: 10526811.
DOI: 10.3390/cancers15184494.
Role of Na/Ca Exchanger (NCX) in Glioblastoma Cell Migration (In Vitro).
Brandalise F, Ramieri M, Pastorelli E, Priori E, Ratto D, Venuti M
Int J Mol Sci. 2023; 24(16).
PMID: 37628853
PMC: 10454658.
DOI: 10.3390/ijms241612673.
Comparison of pharmacological inhibitors of lysine-specific demethylase 1 in glioblastoma stem cells reveals inhibitor-specific efficacy profiles.
Stitzlein L, Gangadharan A, Walsh L, Nam D, Espejo A, Singh M
Front Neurol. 2023; 14:1112207.
PMID: 37082446
PMC: 10111022.
DOI: 10.3389/fneur.2023.1112207.
Phosducin-like 3 is a novel prognostic and onco-immunological biomarker in glioma: A multi-omics analysis with experimental verification.
Peng Z, Wang J, Tong S, Wu Y, Yi D, Xiang W
Front Immunol. 2023; 14:1128151.
PMID: 37006287
PMC: 10050339.
DOI: 10.3389/fimmu.2023.1128151.
Potential clinical treatment prospects behind the molecular mechanism of alternative lengthening of telomeres (ALT).
Sun H, Chen G, Guo B, Lv S, Yuan G
J Cancer. 2023; 14(3):417-433.
PMID: 36860927
PMC: 9969575.
DOI: 10.7150/jca.80097.
Low-Density Lipoprotein Pathway Is a Ubiquitous Metabolic Vulnerability in High Grade Glioma Amenable for Nanotherapeutic Delivery.
Adekeye A, Needham D, Rahman R
Pharmaceutics. 2023; 15(2).
PMID: 36839921
PMC: 9958636.
DOI: 10.3390/pharmaceutics15020599.
